TNGX Competitors & Alternatives
Compare Tango Therapeutics Inc with similar stocks in the same industry
Biotechnology
TNGX
Main Stock$23.24
Tradestie Score
45
Market Cap
$887.30M
Revenue Growth
-1.0%
Analyst Upside
+94.4%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$140.06
|
$3.98B | 135.1 | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$107.39
|
$3.91B | - | 55 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$24.33
|
$3.83B | - | 58 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.37
|
$3.68B | - | 60 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$82.93
|
$3.67B | - | 46 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.72
|
$3.59B | 14.2 | 34 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.95
|
$3.58B | 9.0 | 62 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$302.96
|
$3.49B | 32.1 | 44 | Compare |
More TNGX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry